Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Franzone

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Journal of the American College of Cardiology|October 29, 2013
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathyRoberta Roncarati, Chiara Viviani Anselmi, Maria Angela Losi, et al.
Journal of Thrombosis and Thrombolysis|November 16, 2025
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mgRaffaele Piccolo, Angelo Laino, Antonio Pio Vitale, et al.
Journal of the American Heart Association|May 22, 2013
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failureCinzia Perrino, Gabriele G Schiattarella, Anna Sannino, et al.
Journal of Cardiovascular Translational Research|April 22, 2021
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage ClosureRoberto Galea, Federico De Marco, Adel Aminian, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII RegistryGiuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, et al.
European Heart Journal. Acute Cardiovascular Care|April 15, 2026
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII studyGiuseppe Gargiulo, Viviana Narciso, Imma Forzano, et al.
Cardiovascular Research|June 24, 2015
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligationGiovanni Esposito, Gabriele Giacomo Schiattarella, Cinzia Perrino, et al.
Journal of the American Heart Association|February 4, 2022
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk PatientsCarlo A Pivato, Bernhard Reimers, Luca Testa, et al.
International Journal of Cardiology. Heart & Vasculature|February 22, 2020
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE <i>neo</i> valvePaola Angela Maria Purita, Luisa Salido Tahoces, Chiara Fraccaro, et al.
Hypertension (Dallas, Tex. : 1979)|January 17, 2018
<i>Akap1</i> Regulates Vascular Function and Endothelial Cells BehaviorGabriele Giacomo Schiattarella, Fabio Cattaneo, Albino Carrizzo, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Journal of the American College of Cardiology|October 29, 2013
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathyRoberta Roncarati, Chiara Viviani Anselmi, Maria Angela Losi, et al.
Journal of Thrombosis and Thrombolysis|November 16, 2025
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mgRaffaele Piccolo, Angelo Laino, Antonio Pio Vitale, et al.
Journal of the American Heart Association|May 22, 2013
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failureCinzia Perrino, Gabriele G Schiattarella, Anna Sannino, et al.
Journal of Cardiovascular Translational Research|April 22, 2021
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage ClosureRoberto Galea, Federico De Marco, Adel Aminian, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII RegistryGiuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, et al.
European Heart Journal. Acute Cardiovascular Care|April 15, 2026
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII studyGiuseppe Gargiulo, Viviana Narciso, Imma Forzano, et al.
Cardiovascular Research|June 24, 2015
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligationGiovanni Esposito, Gabriele Giacomo Schiattarella, Cinzia Perrino, et al.
Journal of the American Heart Association|February 4, 2022
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk PatientsCarlo A Pivato, Bernhard Reimers, Luca Testa, et al.
International Journal of Cardiology. Heart & Vasculature|February 22, 2020
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE <i>neo</i> valvePaola Angela Maria Purita, Luisa Salido Tahoces, Chiara Fraccaro, et al.
Hypertension (Dallas, Tex. : 1979)|January 17, 2018
<i>Akap1</i> Regulates Vascular Function and Endothelial Cells BehaviorGabriele Giacomo Schiattarella, Fabio Cattaneo, Albino Carrizzo, et al.
Pageof 18